PDF(Pubmed)
Abstract：
During the last 2 years and a half, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, causing about 6 million deaths. Clinical manifestations are highly variable, ranging from entirely asymptomatic infection to multiorgan failure and death. The outcome in immunocompromised patients is still a matter of debate, and so are the optimal strategies to prevent or treat the infection in these high-risk populations.
摘要：
在过去的两年半，严重急性呼吸道综合症冠状病毒2（SARS-CoV-2）已在全球范围内传播，造成约600万人死亡。临床表现变化很大，从完全无症状感染到多器官衰竭和死亡。免疫功能低下患者的结果仍然是一个争论的问题，在这些高危人群中预防或治疗感染的最佳策略也是如此。
